Catalyst Wire Dossier Catalyst Wire Dossier

Teriparatide intranasal

teriparatide · Azelon Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Teriparatide intranasal, covering 2012-05-23 to 2012-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass [Phase 2]

See pricing